Cervical Cytology ICE system user manual

Directorate of Laboratory Medicine 3 | Page 2. Patient records 2.1. Searching for a patient Once logged‐in you should see the page below, use NHS number only to perform a

  Laboratory, Directorate, Directorate of laboratory

Manchester Hospitals (MFT) Anaemia Guide Version 4 Aug ...

- In non-vegans treatment can be stopped once vitamin B12 levels have been corrected and diet has improved – but monitor B12 levels 6 monthly Advise consumption of foods rich in vitamin B12, eg: foods fortified with vitamin B12 - some soy products, and some breakfast cereals and breads, meat, eggs, and dairy products

  Vitamin, Vitamin b12

Title: Obstetric Cholestasis (OC) diagnosis and management ...

Risk of stillbirth is unclear but reported to be up to 1-2% when bile acids are > 40mmol/L (Glantz et al, 2004). 2.3. Maternal risks: Maternal morbidity associated with severe pruritus leading to insomnia and exhaustion. Iatrogenic risks from increased rate of induction of labour (Geenes et al, 2014; RCOG, 2011).

  Management, Diagnosis, Obstetrics, Diagnosis and management, Stillbirth, Cholestasis, Obstetric cholestasis

Using steroid ointment on the vulva

skin conditions of the vulva, such as lichen sclerosus or lichen planus. They are safe and highly effective, but often women will have anxiety about using steroids and be fearful of side effects. This often causes them to use less than they should …

  Using, Steroid, Lichen, Ointment, Lichen sclerosus, Sclerosus, Vulva, Using steroid ointment on the vulva

ADULT HAEMATOLOGY GP Pathway Guides

High Risk MGUS • IgG>15 • IgM and Ig A>10 Low Risk MGUS • IgG <15 • IgM and IgA <10 • SFLC ratio <8 or >0.1 • No Organ Damage Non-urgent referral to Haematology Urgent referral to . Microcytic Anaemia Microcytic Anaemia

  Pathway, Haematology, Mgus, Haematology gp pathway

Faecal Immunochemical Testing (FIT)

still follow the 2WW urgent referral pathway Use of FIT in primary care could result in avoidance of invasive tests for patients with negative results. Shorter waiting times for colonoscopies for higher risk patients (including those with FIT positive results).

  Referral

Cervical Ectopy (Cervical Erosion)

Bleeding can also occur if a vaginal infection such as thrush or bacterial vaginosis is present as these common conditions irritate the area. Some women have no symptoms at all and are only diagnosed with an ectopy on routine examinations such as smear tests. What if I’m pregnant? Cervical ectopy is very common during pregnancy.

  Bacterial, Vaginosis, Bacterial vaginosis

HbA1c

HbA1c ≤ 48 is tight control and suitable for most patients with type 2 diabetes unless at risk of hypoglycaemia HbA1c ≤ 53 is the target for those at risk of hypoglycaemia HbA1c <58 is good control but lower targets may be appropriate depending on the individual

  Control, Tight, Tight control

OCCUPATIONAL THERAPY ADVICE

Occupational therapist to complete pre-school and/or home observation to outline potential sensory difficulties. Review sensory assessment accepted. Page 5 of 43 Trafford Children’s Therapy Service Complied by Alannah Mckaskie (OT) - Version 1 (2018)

  Occupational, Sensory

Sarstedt’s Monovette Instructions for Use

Fluoride Citrate-Fluoride 10 min. 2,000 x g 1,800 - 2,500 x g Glucose The S-Monovette® Glucose contains fluoride (1.0 mg/ml blood) as a glycolysis inhibitor, and liquid EDTA (1.2 mg/ml blood) as an anticoagulant. The S-Monovette® GlucoExact …

  Fluoride

PACKAGE LEAFLET: INFORMATION FOR THE USER Spiolto …

2.5 microgram/2.5 microgram, inhalation solution tiotropium/olodaterol Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist.

  Information, User, Leaflet, Packages, Package leaflet, Information for the user, Micrograms

London, 20 November 2008 - European Commission

microgram, not 0.25 mg). However, where a range of medicinal products of the same pharmaceutical form includes strengths of more than one unit (e.g. 250 microgram, 1 mg and 6 mg), it may be more appropriate in certain cases to state the strengths in the same unit for the purpose of comparability (e.g. 0.25 mg, 1 mg and 6 mg).

  European commission, European, Commission, Micrograms

A Rapid and Sensitive Method for the Quantitation of ...

Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding MARION M. BRADFORD Reproduction Research Laboratories, Department of Biochemistry, University of Georgia, Athens, Georgia 30602 Received September 11, 1975; accepted January 29, 1976

  Micrograms, Bradford

Quantity Limit Program - BCBSM

SC = subcutaneous, mg = milligram, gm = gram, mcg = microgram, ml = milliliter, IU = international unit Not covered: You may be responsible for the full cost of the medication. Not applicable: Quantity limits may not apply. Sample Abilify MyCite = brand name (aripiprazole) = generic name Quantity limits for: Medication BCBSM Clinical ,CustomClosed

  Programs, Limits, Quantity, Micrograms, Quantity limit program

Formulas for Calculating Medication Dosage

Calculating by microgram per kilogram per minute (mcg/kg/min) Ordered mcg/kg/min x Patient weight in kg x 60 minutes/h ----- = mL/h Medication concentration (mcg/1 mL) 800 mg of dopamine is added to 250 ml of .9%Ns. The order is to begin the infusion at 3 mcg/kg/minute.

  Micrograms

UNITED KINGDOM USER PACKAGE LEAFLET OF CERAZETTE

75 microgram film-coated tablets . desogestrel . Read all of this leaflet carefully before you start using this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have any further questions, please ask your doctor, pharmacist or Family Planning Nurse.

  Micrograms

Pfizer-BioNTech COVID-19 Vaccines

10/7/2021 Pfizer-BioNTech COVID-19 Vaccines PRELIMINARY – SUBJECT TO CHANGE PENDING REGULATORY GUIDANCE AND AUTHORIZATION/APPROVAL *Diluent: 0.9% sterile Sodium Chloride Injection, USP (non-bacteriostatic; DO NOT USE OTHER DILUENTS)

AUSTRALIAN PRODUCT INFORMATION – COMIRNATY …

Version: pfpcovii50121 Supersedes: N/A Page 3 of 15 Attachment 1: AusPAR – COMIRNATY - BNT162b2 (mRNA) - Pfizer Australia Pty Ltd - PM-2020-05461-1-2

  Information, Product, Product information